Pharmacologic Therapy for Acne: A Primer for Primary Care

Author and Disclosure Information

Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.

Expires September 30, 2018

Many of the 50 million persons affected by acne in the United States present to primary care. Acne severity guides treatment choices, which include topical antibiotics and retinoids, hormonal agents, and systemic antibiotics and retinoids. Formulating a treatment plan requires a thorough understanding of the dosing, mechanism of action, and potential adverse effects of available medications.



CE/CME No: CR-1710

Earn credit by reading this article and successfully completing the posttest and evaluation. Successful completion is defined as a cumulative score of at least 70% correct.

• Describe the main factors involved in the pathogenesis of acne.
• Assess acne severity and classify acne as mild, moderate, or severe.
• Describe available acne therapies, including their mechanisms of action, indications, and potential adverse effects.
• Identify strategies patients can employ to mitigate the adverse effects of acne treatments.

Janet Purath is an Associate Professor at Washington State University in Spokane, Washington. Theresa Coyner practices at Randall Dermatology, West Lafayette, Indiana.

The authors have no financial relationships to disclose.


This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category 1 CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid through September 30, 2018.

Article begins on next page >>


Next Article:

Few patients follow recommendation to use OTC benzoyl peroxide

Related Articles